Pharmacodynamics and bactericidal activity of ceftriaxone (CRO) therapy in eiperimental cephalosporin-resistant pneumococcal (CRSP) meningitis

I. Lutsar, A. Ahmed, I. R. Freedland, L. Wubbel, M. Trujillo, K. Olsen, G. H. McCracken

Research output: Contribution to journalArticle

Abstract

Adequate cerebrospinal fluid (CSF) concentrations and activity of β-lactam antibiotics are difficult to achieve in meningitis caused by drug-resistant Streptococcus pneumonias. Aim: To compare the pharmacodynamic and bacteriologic effectiveness of different dosing regimens of CRO in experimental CRSP meningitis. Methods: Meningitis was induced in rabbits by intracisternal inoculation of CRSP (MIC & MBC = 4μg/ml). CRO (150-400 mg/kg/day) was given IV in one or two doses. The correlation between bacterial killing rate (BKR) (Δ log 10 CFU/ml/h) and percentage of time that CRO conc, exceeded the MBC (T > MBC), C peak/MBC or AUC/MBC in CSF was determined. Results: CSF CRO conc exceeded the MBC within 30 minutes of administration in all animals. In the first 24 hours the 200 mg/kg/q12h regimen, compared with 400 mg/kg/q24h regimen, was associated with a greater T > MBC (87 ± 10% vs 60 ± 22%; p = 0.03) and greater BKR (0.2 ± 0.04 vs 0.13 ± 0.07; p = 0.003). However, CSF bacterial concentrations were similar by 48 h. By stepwise multiple regression only T > MBC in CSF during the first 24 h of therapy correlated independently with the BKR (p = 0.001); other indices (C peak/MBC and AUC/MBC) were strongly related to T > MBC and did not correlate independently with BKR. T > MBC of 95-100% was needed for sterilization of the CSF in 24 h. Conclusion: The T > MBC of CRO in CSF is the most important determinant of bacteriologic effictiveness in experimental highly CRSP meningitis. In the first 24 h twice daily dosing of CRO was more rapidly bactericidal than daily dosing.

Original languageEnglish (US)
Pages (from-to)487
Number of pages1
JournalClinical Infectious Diseases
Volume25
Issue number2
StatePublished - 1997

Fingerprint

Pneumococcal Meningitis
Ceftriaxone
Cephalosporins
Cerebrospinal Fluid
Meningitis
Therapeutics
Area Under Curve
Lactams
Streptococcus pneumoniae
Anti-Bacterial Agents
Rabbits

ASJC Scopus subject areas

  • Immunology

Cite this

Pharmacodynamics and bactericidal activity of ceftriaxone (CRO) therapy in eiperimental cephalosporin-resistant pneumococcal (CRSP) meningitis. / Lutsar, I.; Ahmed, A.; Freedland, I. R.; Wubbel, L.; Trujillo, M.; Olsen, K.; McCracken, G. H.

In: Clinical Infectious Diseases, Vol. 25, No. 2, 1997, p. 487.

Research output: Contribution to journalArticle

@article{b5c68b116116464fa5924f20773ab882,
title = "Pharmacodynamics and bactericidal activity of ceftriaxone (CRO) therapy in eiperimental cephalosporin-resistant pneumococcal (CRSP) meningitis",
abstract = "Adequate cerebrospinal fluid (CSF) concentrations and activity of β-lactam antibiotics are difficult to achieve in meningitis caused by drug-resistant Streptococcus pneumonias. Aim: To compare the pharmacodynamic and bacteriologic effectiveness of different dosing regimens of CRO in experimental CRSP meningitis. Methods: Meningitis was induced in rabbits by intracisternal inoculation of CRSP (MIC & MBC = 4μg/ml). CRO (150-400 mg/kg/day) was given IV in one or two doses. The correlation between bacterial killing rate (BKR) (Δ log 10 CFU/ml/h) and percentage of time that CRO conc, exceeded the MBC (T > MBC), C peak/MBC or AUC/MBC in CSF was determined. Results: CSF CRO conc exceeded the MBC within 30 minutes of administration in all animals. In the first 24 hours the 200 mg/kg/q12h regimen, compared with 400 mg/kg/q24h regimen, was associated with a greater T > MBC (87 ± 10{\%} vs 60 ± 22{\%}; p = 0.03) and greater BKR (0.2 ± 0.04 vs 0.13 ± 0.07; p = 0.003). However, CSF bacterial concentrations were similar by 48 h. By stepwise multiple regression only T > MBC in CSF during the first 24 h of therapy correlated independently with the BKR (p = 0.001); other indices (C peak/MBC and AUC/MBC) were strongly related to T > MBC and did not correlate independently with BKR. T > MBC of 95-100{\%} was needed for sterilization of the CSF in 24 h. Conclusion: The T > MBC of CRO in CSF is the most important determinant of bacteriologic effictiveness in experimental highly CRSP meningitis. In the first 24 h twice daily dosing of CRO was more rapidly bactericidal than daily dosing.",
author = "I. Lutsar and A. Ahmed and Freedland, {I. R.} and L. Wubbel and M. Trujillo and K. Olsen and McCracken, {G. H.}",
year = "1997",
language = "English (US)",
volume = "25",
pages = "487",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Pharmacodynamics and bactericidal activity of ceftriaxone (CRO) therapy in eiperimental cephalosporin-resistant pneumococcal (CRSP) meningitis

AU - Lutsar, I.

AU - Ahmed, A.

AU - Freedland, I. R.

AU - Wubbel, L.

AU - Trujillo, M.

AU - Olsen, K.

AU - McCracken, G. H.

PY - 1997

Y1 - 1997

N2 - Adequate cerebrospinal fluid (CSF) concentrations and activity of β-lactam antibiotics are difficult to achieve in meningitis caused by drug-resistant Streptococcus pneumonias. Aim: To compare the pharmacodynamic and bacteriologic effectiveness of different dosing regimens of CRO in experimental CRSP meningitis. Methods: Meningitis was induced in rabbits by intracisternal inoculation of CRSP (MIC & MBC = 4μg/ml). CRO (150-400 mg/kg/day) was given IV in one or two doses. The correlation between bacterial killing rate (BKR) (Δ log 10 CFU/ml/h) and percentage of time that CRO conc, exceeded the MBC (T > MBC), C peak/MBC or AUC/MBC in CSF was determined. Results: CSF CRO conc exceeded the MBC within 30 minutes of administration in all animals. In the first 24 hours the 200 mg/kg/q12h regimen, compared with 400 mg/kg/q24h regimen, was associated with a greater T > MBC (87 ± 10% vs 60 ± 22%; p = 0.03) and greater BKR (0.2 ± 0.04 vs 0.13 ± 0.07; p = 0.003). However, CSF bacterial concentrations were similar by 48 h. By stepwise multiple regression only T > MBC in CSF during the first 24 h of therapy correlated independently with the BKR (p = 0.001); other indices (C peak/MBC and AUC/MBC) were strongly related to T > MBC and did not correlate independently with BKR. T > MBC of 95-100% was needed for sterilization of the CSF in 24 h. Conclusion: The T > MBC of CRO in CSF is the most important determinant of bacteriologic effictiveness in experimental highly CRSP meningitis. In the first 24 h twice daily dosing of CRO was more rapidly bactericidal than daily dosing.

AB - Adequate cerebrospinal fluid (CSF) concentrations and activity of β-lactam antibiotics are difficult to achieve in meningitis caused by drug-resistant Streptococcus pneumonias. Aim: To compare the pharmacodynamic and bacteriologic effectiveness of different dosing regimens of CRO in experimental CRSP meningitis. Methods: Meningitis was induced in rabbits by intracisternal inoculation of CRSP (MIC & MBC = 4μg/ml). CRO (150-400 mg/kg/day) was given IV in one or two doses. The correlation between bacterial killing rate (BKR) (Δ log 10 CFU/ml/h) and percentage of time that CRO conc, exceeded the MBC (T > MBC), C peak/MBC or AUC/MBC in CSF was determined. Results: CSF CRO conc exceeded the MBC within 30 minutes of administration in all animals. In the first 24 hours the 200 mg/kg/q12h regimen, compared with 400 mg/kg/q24h regimen, was associated with a greater T > MBC (87 ± 10% vs 60 ± 22%; p = 0.03) and greater BKR (0.2 ± 0.04 vs 0.13 ± 0.07; p = 0.003). However, CSF bacterial concentrations were similar by 48 h. By stepwise multiple regression only T > MBC in CSF during the first 24 h of therapy correlated independently with the BKR (p = 0.001); other indices (C peak/MBC and AUC/MBC) were strongly related to T > MBC and did not correlate independently with BKR. T > MBC of 95-100% was needed for sterilization of the CSF in 24 h. Conclusion: The T > MBC of CRO in CSF is the most important determinant of bacteriologic effictiveness in experimental highly CRSP meningitis. In the first 24 h twice daily dosing of CRO was more rapidly bactericidal than daily dosing.

UR - http://www.scopus.com/inward/record.url?scp=33748196918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748196918&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748196918

VL - 25

SP - 487

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 2

ER -